These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2716524)

  • 1. Platelet aggregation measured by the photometric method.
    Zucker MB
    Methods Enzymol; 1989; 169():117-33. PubMed ID: 2716524
    [No Abstract]   [Full Text] [Related]  

  • 2. [The continuous measurement of platelet aggregation without addition of aggregation stimulators. I. Methods and clinical results].
    Jäger W; Kutschera J; Wendeberg H; Kauschmann R; Riese W; Pietsch U; Berger E; Bennert C
    Blut; 1974 Sep; 29(3):184-94. PubMed ID: 4411130
    [No Abstract]   [Full Text] [Related]  

  • 3. Recognition and prevention of pseudothrombocytopenia and concomitant pseudoleukocytosis.
    Lombarts AJ; de Kieviet W
    Am J Clin Pathol; 1988 May; 89(5):634-9. PubMed ID: 3128946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pH and concentration of sodium citrate anticoagulant on platelet aggregation measured by light transmission aggregometry induced by adenosine diphosphate.
    Germanovich K; Femia EA; Cheng CY; Dovlatova N; Cattaneo M
    Platelets; 2018 Jan; 29(1):21-26. PubMed ID: 28643541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Measurement of spontaneous platelet aggregation. Platelet aggregation test III (author's transl)].
    Breddin K; Grun H; Krzywanek HJ; Schremmer WP
    Klin Wochenschr; 1975 Jan; 53(2):81-9. PubMed ID: 238058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-thromboglobulin (beta tg) and platelet factor 4 (PF4) in patients with myeloproliferative diseases.
    Fabris F; Luzzatto G; Randi ML; Cella G
    Thromb Haemost; 1994 Sep; 72(3):484-6. PubMed ID: 7710537
    [No Abstract]   [Full Text] [Related]  

  • 7. Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents.
    Lages B; Weiss HJ
    Thromb Haemost; 1981 Apr; 45(2):173-9. PubMed ID: 6789496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: A.C.D. and C.P.D. blood preservation.
    Wright G; Sanderson JM
    Lancet; 1974 Jul; 2(7873):173. PubMed ID: 4135439
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of equine platelet function and survival in whole blood collected in acid-citrate-dextrose solution or citrate-phosphate-dextrose-adenine solution.
    Bozorgmanesh R; Sutton-Burges JW; Tablin F
    Vet Clin Pathol; 2017 Jun; 46(2):262-268. PubMed ID: 28411369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different anticoagulant associations on haemostasis and biochemical analyses in feline blood specimens.
    Granat F; Monzali C; Jeunesse E; Guerlin M; Trumel C; Geffré A; Bourgès-Abella N
    J Feline Med Surg; 2017 Apr; 19(4):394-402. PubMed ID: 26887655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preanalytical aspects of coagulation testing.
    Narayanan S
    Haematologica; 1995; 80(2 Suppl):1-6. PubMed ID: 7628761
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: The photometric aggregation test (PAT III). A screening test for enhanced platelet aggregation.
    Krzywanek HJ; Breddin K
    Thromb Diath Haemorrh; 1975 Nov; 34(2):579. PubMed ID: 1198480
    [No Abstract]   [Full Text] [Related]  

  • 13. Methodological considerations for the assessment of ADP induced platelet aggregation using the Multiplate® analyser.
    Johnston LR; Larsen PD; La Flamme AC; Harding SA
    Platelets; 2013; 24(4):303-7. PubMed ID: 22686487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of anticoagulants and extracellular divalent cations on blood platelet behaviour [proceedings].
    Heptinstall S; Taylor PM
    J Physiol; 1978 Mar; 276(Suppl):25P-26P. PubMed ID: 650446
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anticoagulants preventing pseudo-thrombocytopenia].
    Nagata T; Tanaka K; Suzuki K; Minoura T; Fujita N; Nakanishi S; Takahashi H; Yoshimura M
    Rinsho Byori; 1992 Jan; 40(1):87-92. PubMed ID: 1545530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of platelet aggregation measured with 3 different methods (photometric and impedance) in ticlopidine treated patients.
    Lecrubier C; Girard P; Noire P; Samama M
    Agents Actions Suppl; 1984; 15():60-7. PubMed ID: 6592946
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of different anticoagulants in test tubes for analysis of blood lactate concentrations: Part 2. Implications for the proper handling of blood specimens obtained from critically ill patients.
    Wiese J; Didwania A; Kerzner R; Chernow B
    Crit Care Med; 1997 Nov; 25(11):1847-50. PubMed ID: 9366768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities.
    Gerlach RF; Uzuelli JA; Souza-Tarla CD; Tanus-Santos JE
    Anal Biochem; 2005 Sep; 344(1):147-9. PubMed ID: 15950912
    [No Abstract]   [Full Text] [Related]  

  • 19. [Problems in testing platelet aggregation].
    Wang Z
    Sheng Li Ke Xue Jin Zhan; 1983 Apr; 14(2):182-5. PubMed ID: 6612303
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition and reversal of platelet aggregation by alphaIIbbeta3 antagonists depends on the anticoagulant and flow conditions: differential effects of Abciximab and Lamifiban.
    Frojmovic M; Labarthe B; Legrand C
    Br J Haematol; 2005 Nov; 131(3):348-55. PubMed ID: 16225655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.